Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1979 Jun 23;1(6179):1689–1691. doi: 10.1136/bmj.1.6179.1689

Cis-platinum: a new anticancer agent.

C J Williams, J M Whitehouse
PMCID: PMC1599237  PMID: 380759

Full text

PDF
1689

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruckner H. W., Ratner L. H., Cohen C. J., Wallach R., Kabakow B., Greenspan E. M., Holland J. F. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy. Cancer Treat Rep. 1978 Jul;62(7):1021–1023. [PubMed] [Google Scholar]
  2. Chary K. K., Higby D. J., Henderson E. S., Swinerton K. D. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis. Cancer Treat Rep. 1977 May-Jun;61(3):367–370. [PubMed] [Google Scholar]
  3. Dentino M., Luft F. C., Yum M. N., Williams S. D., Einhorn L. H. Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer. 1978 Apr;41(4):1274–1281. doi: 10.1002/1097-0142(197804)41:4<1274::aid-cncr2820410410>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  4. Einhorn L. H., Donohue J. P. Chemotherapy for disseminated testicular cancer. Urol Clin North Am. 1977 Oct;4(3):407–426. [PubMed] [Google Scholar]
  5. Einhorn L. H., Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 1977 Sep;87(3):293–298. doi: 10.7326/0003-4819-87-3-293. [DOI] [PubMed] [Google Scholar]
  6. Einhorn L. H., Williams S. D. The role of cis-platinum in solid-tumor therapy. N Engl J Med. 1979 Feb 8;300(6):289–291. doi: 10.1056/NEJM197902083000605. [DOI] [PubMed] [Google Scholar]
  7. Gonzales-Vitale J. C., Hayes D. M., Cvitkovic E., Sternberg S. S. The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer. 1977 Apr;39(4):1362–1371. doi: 10.1002/1097-0142(197704)39:4<1362::aid-cncr2820390403>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  8. Harder H. C., Rosenberg B. Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro. Int J Cancer. 1970 Sep 15;6(2):207–216. doi: 10.1002/ijc.2910060207. [DOI] [PubMed] [Google Scholar]
  9. Hayes D. M., Cvitkovic E., Golbey R. B., Scheiner E., Helson L., Krakoff I. H. High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Cancer. 1977 Apr;39(4):1372–1381. doi: 10.1002/1097-0142(197704)39:4<1372::aid-cncr2820390404>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  10. Hill J. M., Loeb E., MacLellan A., Hill N. O., Khan A., King J. J. Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases. Cancer Chemother Rep. 1975 May-Jun;59(3):647–659. [PubMed] [Google Scholar]
  11. Howle J. A., Gale G. R. Cis-dichlorodiammineplatinum (II). Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo. Biochem Pharmacol. 1970 Oct;19(10):2757–2762. doi: 10.1016/0006-2952(70)90102-4. [DOI] [PubMed] [Google Scholar]
  12. Kamalakar P., Freeman A. I., Higby D. J., Wallace H. J., Jr, Sinks L. F. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children. Cancer Treat Rep. 1977 Aug;61(5):835–839. [PubMed] [Google Scholar]
  13. Krikorian J. G., Daniels J. R., Brown B. W., Jr, Hu M. S. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin. Cancer Treat Rep. 1978 Oct;62(10):1455–1463. [PubMed] [Google Scholar]
  14. Platinum complexes in cancer chemotherapy. Antibiot Chemother (1971) 1978;23:99–112. [PubMed] [Google Scholar]
  15. ROSENBERG B., VANCAMP L., KRIGAS T. INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE. Nature. 1965 Feb 13;205:698–699. doi: 10.1038/205698a0. [DOI] [PubMed] [Google Scholar]
  16. Rosenberg B. Noble metal complexes in cancer chemotherapy. Adv Exp Med Biol. 1977;91:129–150. doi: 10.1007/978-1-4684-0796-9_10. [DOI] [PubMed] [Google Scholar]
  17. Rozencweig M., von Hoff D. D., Slavik M., Muggia F. M. Cis-diamminedichloroplatinum (II). A new anticancer drug. Ann Intern Med. 1977 Jun;86(6):803–812. doi: 10.7326/0003-4819-86-6-803. [DOI] [PubMed] [Google Scholar]
  18. Shechter Y., Schlessinger J., Jacobs S., Chang K. J., Cuatrecasas P. Fluorescent labeling of hormone receptors in viable cells: preparation and properties of highly fluorescent derivatives of epidermal growth factor and insulin. Proc Natl Acad Sci U S A. 1978 May;75(5):2135–2139. doi: 10.1073/pnas.75.5.2135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Williams C. Current dilemmas in the management of non-seminomatous germ cell tumors of the testis. Cancer Treat Rev. 1977 Dec;4(4):275–297. doi: 10.1016/s0305-7372(77)80003-0. [DOI] [PubMed] [Google Scholar]
  20. Wiltshaw E., Kroner T. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary. Cancer Treat Rep. 1976 Jan;60(1):55–60. [PubMed] [Google Scholar]
  21. Yagoda A., Watson R. C., Gonzalez-Vitale J. C., Grabstald H., Whitmore W. F. Cis-dichlorodiammineplatinum(II) in advanced bladder cancer. Cancer Treat Rep. 1976 Jul;60(7):917–923. [PubMed] [Google Scholar]
  22. Yagoda A., Watson R. C., Gonzalez-Vitale J. C., Grabstald H., Whitmore W. F. Cis-dichlorodiammineplatinum(II) in advanced bladder cancer. Cancer Treat Rep. 1976 Jul;60(7):917–923. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES